Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: Formation of adrenochrome, quinoproteins, and GSH adduct

被引:59
作者
Costa, Vera Marisa
Silva, Renata
Ferreira, Luisa Maria
Branco, Paula Serio
Carvalho, Felix
Bastos, Maria Lourdes
Carvalho, Rui Albuquerque
Carvalho, Marcia
Remiao, Fernando
机构
[1] Univ Porto, Fac Farm, Dept Toxicol, REQUIMTE, P-4099030 Oporto, Portugal
[2] Univ Nova Lisboa, Fac Sci & Technol, Dept Chem, REQUIMTE CQFB, Monte De Caparica, Portugal
[3] Univ Coimbra, Neurosci Ctr Coimbra, Coimbra, Portugal
[4] Univ Fernando Pessoa, Fac Hlth Sci, Oporto, Portugal
关键词
D O I
10.1021/tx7000916
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
High concentrations of circulating biogenic catecholamines often exist during the course of several cardiovascular disorders. Additionally, coronary dysfunctions are prominent and frequently related to the ischemic and reperfusion phenomenon (I/R) in the heart, which leads to the release of large amounts of catecholamines, namely adrenaline, and to a sustained generation of reactive oxygen species (ROS). Thus, this work aimed to study the toxicity of adrenaline either alone or in the presence of a system capable of generating ROS [xanthine with xanthine oxidase (X/XO)], in freshly isolated, calcium tolerant cardiomyocytes from adult rats. Studies were performed for 3 h, and cardiomyocyte viability, ATP level, lipid peroxidation, protein carbonylation content, and glutathione status were evaluated, in addition to the formation of adrenalines oxidation products and quinoproteins. Intracellular GSH levels were time-dependently depleted with no GSSG formation when cardiomyocytes were exposed to adrenaline or to adrenaline with X/XO. Meanwhile, a time-dependent increase in the rate of formation of adrenochrome and quinoproteins was observed. Additionally, as a new outcome, 5-(glutathion- S-yl)adrenaline, an adrenaline adduct of glutathione, was identified and quantified. Noteworthy is the fact that the exposure to adrenaline alone promotes a higher rate of formation of quinoproteins and glutathione adduct, while adrenochrome formation is favored where ROS production is stimulated. This study shows that the redox status of the surrounding environment greatly influences adrenalines oxidation pathway, which may trigger cellular changes responsible for cardiotoxicity.
引用
收藏
页码:1183 / 1191
页数:9
相关论文
共 65 条
[1]  
[Anonymous], 2003, The world health report 2003: shaping the future
[2]   Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy [J].
Baldus, Stephan ;
Muellerleile, Kai ;
Chumley, Phil ;
Steven, Daniel ;
Rudolph, Volker ;
Lund, Gunnar K. ;
Staude, Hans-Juergen ;
Stork, Alexander ;
Koester, Ralf ;
Kaehler, Jan ;
Weiss, Christian ;
Muenzel, Thomas ;
Meinertz, Thomas ;
Freeman, Bruce A. ;
Heitzer, Thomas .
FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 (08) :1282-1288
[3]   Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes) [J].
Behonick, GS ;
Novak, MJ ;
Nealley, EW ;
Baskin, SI .
JOURNAL OF APPLIED TOXICOLOGY, 2001, 21 :S15-S22
[4]   DIRECT AND RESPIRATORY CHAIN-MEDIATED REDOX CYCLING OF ADRENOCHROME [J].
BINDOLI, A ;
DEEBLE, DJ ;
RIGOBELLO, MP ;
GALZIGNA, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1016 (03) :349-356
[5]   BIOCHEMICAL AND TOXICOLOGICAL PROPERTIES OF THE OXIDATION-PRODUCTS OF CATECHOLAMINES [J].
BINDOLI, A ;
RIGOBELLO, MP ;
DEEBLE, DJ .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :391-405
[6]   TOXICITY OF AMINOCHROMES [J].
BINDOLI, A ;
RIGOBELLO, MP ;
GALZIGNA, L .
TOXICOLOGY LETTERS, 1989, 48 (01) :3-20
[7]   The role of adrenochrome in stimulating the oxidation of catecholamines [J].
Bindoli, Alberto ;
Scutari, Guido ;
Rigobello, Maria Pia .
NEUROTOXICITY RESEARCH, 1999, 1 (02) :71-80
[8]   Role of quinones in toxicology [J].
Bolton, JL ;
Trush, MA ;
Penning, TM ;
Dryhurst, G ;
Monks, TJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (03) :135-160
[9]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[10]  
Broadley K. J., 2004, Autonomic & Autacoid Pharmacology, V24, P87, DOI 10.1111/j.1474-8673.2004.00324.x